Signaling Pathways
A basic property of living systems is the ability to respond to extracellular signals by evoking an internal response. Signal-transduction cascades mediate the sensing and processing of these stimuli. These molecular circuits detect, amplify, and integrate diverse external signals to generate responses such as changes in enzyme activity, gene expression, phenotypic alterations, or ion-channel activity. Signal-transduction pathways follow a broadly similar course that can be viewed as a molecular circuit. Upon an environmental signal, Membrane receptors transfer information from the environment to the cell's interior. Subsequently, second messengers relay information from the receptor-ligand complex into the cell's interior. Particularly important second messengers include cyclic AMP and cyclic GMP, calcium ion, inositol 1,4,5-trisphosphate, (IP3), and diacylglycerol. While these second messengers are free to move, they can easily diffuse to other compartments of the cell, such as the nucleus, where they can influence gene expression and other processes. Interestingly, signal transduction may be amplified significantly in the generation of second messengers, since initial stimulation may lead to the generation of many second messengers within the cell. Thus, a low concentration of signal in the environment, even as little as a single molecule, can yield a large intracellular signal and response. Besides this phenomenon, cross-talk between two or more signaling cascades may occur, which permits more finely tuned regulation of cell activity than would the action of individual independent pathways[1]
[1] Signal-Transduction Pathways: An Introduction to Information Metabolism. Biochemistry. 5th edition. J.M. Berg, J.L.Tymoczko, L. Stryer.New York, 2002.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
2467 | (+)-ITD-1 | Selective inhibitor of TGFβ/Smad signaling that promotes cardiogenesis | €165.00 | |
1744 | A 77-01 | TGF-βR 1 inhibitor; ALK 5 inhibitor | €80.00 | |
1421 | A 83-01 | TGF-βR 1 inhibitor; ALK 5 inhibitor | €70.00 | |
4168 | BMS-986260 | Potent, selective and orally bioavailable TGF-βR 1 inhibitor | €120.00 | |
3914 | CDD-1653 | First-in-class, highly potent, and selective BMPR2 kinase inhibitor | €110.00 | |
1708 | Dorsomorphin | Inhibitor of BMP signaling. Inhibits ALK2, 3 and 6 | €65.00 | |
2150 | Dorsomorphin dihydrochloride | Inhibitor of BMP signaling. Inhibits ALK2, 3 and 6 | €65.00 | |
1832 | GW 788388 | TGF-βR 1 inhibitor | €50.00 | |
2236 | IN 1130 | TGF-βR 1 inhibitor | €95.00 | |
2323 | ITD 1 | Selective inhibitor of TGFβ/Smad signaling that promotes cardiogenesis | €105.00 | |
2189 | K 02288 | Inhibitor of BMP signaling. Inhibits ALK1, 2, and 6 | €90.00 | |
1509 | LDN 193189 hydrochloride | Highly potent small molecule inhibitor of BMP type I receptors ALK2, ALK3, and ALK6 | €65.00 | |
3552 | LDN 212854 | Potent ALK2-biased BMP type I receptor kinase inhibitor | €110.00 | |
2201 | LDN 212854 trihydrochloride | Potent ALK2-biased BMP type I receptor kinase inhibitor | €110.00 | |
1491 | LY 2157299 | TGF-βR2 inhibitor | €60.00 | |
3892 | LY-3200882 | TGF-βR 1 inhibitor | Inquire | |
3404 | LY-364947 | Potent, selective and ATP-competitive TGF-βR 1 inhibitor | €90.00 | |
1661 | SB 431542 | TGF-βR1 inhibitor; ALK inhibitor | €70.00 | |
2197 | SB 505124 | Selective inhibitor of TGF-β type I receptors ALK4 and ALK5 | €95.00 | |
2285 | SB 525334 | Potent and selective inhibitor of the TGF-βR1 (ALK5) receptor | €105.00 | |
4165 | SB4 | Potent BMP agonist | €80.00 | |
1387 | SD 208 | TGF-βR 1 inhibitor | €50.00 | |
2903 | SJ000291942 | Activator of the canonical BMP signaling pathway | €95.00 | |
2943 | SRI-011381 hydrochloride | TGF-β signaling agonist | €125.00 | |
5004 | Stem Cell LSB inhibitor Set | Set of BMP inhibitor LDN 193189 (Axon 1509) and TGF-β inhibitor SB 431542 (Axon 1661) | €90.00 | |
5005 | Stem Cell LSC inhibitor Set | Set of LDN 193189 HCl, SB 431542 and CHIR99021, inhibitors of BMP, TGF-β, and GSK-3 resp. | €130.00 | |
3076 | TJ191 | Potent and selective anti-cancer agent targeting low TβRIII-expressing malignant T-cell leukemia/lymphoma cells | €120.00 |